103 related articles for article (PubMed ID: 25116677)
1. Higher levels of hepatitis C virus RNA found in blood donors co-infected with HIV as compared to HCV mono-infected donors.
Alidjinou EK; Moukassa D; Ebatetou-Ataboho E; Mahoungou GH; Pambou JP; Sané F; Prevost B; Bocket L; Ibara JR; Hober D
J Infect Dev Ctries; 2014 Aug; 8(8):1068-71. PubMed ID: 25116677
[TBL] [Abstract][Full Text] [Related]
2. [An investigation of clinical features and immunological functions of HCV-specific cytotoxic T lymphocytes in HIV/HCV co-infected patients].
DU XF; Zhang YH; Ma LN; Yan HP; Chen XY; Wu H
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):345-8. PubMed ID: 18510845
[TBL] [Abstract][Full Text] [Related]
3. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
[TBL] [Abstract][Full Text] [Related]
4. [A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].
Long L; Liu Y; Duan Z; Xu Q; Shen T; Dou X; Zhuang H; Lu F
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):244-50. PubMed ID: 25173220
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study.
Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J;
J Viral Hepat; 2015 Sep; 22(9):708-17. PubMed ID: 25580520
[TBL] [Abstract][Full Text] [Related]
6. Medically assisted procreation and transmission of hepatitis C virus: absence of HCV RNA in purified sperm fraction in HIV co-infected patients.
Halfon P; Giorgetti C; Bourlière M; Chabert-Orsoni V; Khiri H; Pénaranda G; Chincholle JM; Gallais H; Ravaux I; Moreau J; Gastaud JA; Roulier R
AIDS; 2006 Jan; 20(2):241-6. PubMed ID: 16511417
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D
J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
[TBL] [Abstract][Full Text] [Related]
8. HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection.
Neukam K; García-Rey S; Cifuentes C; Macías J; Mira JA; Vázquez MJ; Parra-Sánchez M; Palomares JC; Merchante N; Di Lello FA; Pineda JA
Antiviral Res; 2012 Sep; 95(3):212-5. PubMed ID: 22750672
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia.
Melendez-Morales L; Konkle BA; Preiss L; Zhang M; Mathew P; Eyster ME; Goedert JJ
AIDS; 2007 Jul; 21(12):1631-6. PubMed ID: 17630559
[TBL] [Abstract][Full Text] [Related]
10. Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users.
Jamalidoust M; Namayandeh M; Moghadami M; Ziyaeyan M
Virol J; 2017 Jul; 14(1):127. PubMed ID: 28697809
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
[TBL] [Abstract][Full Text] [Related]
12. IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV.
Falconer K; Askarieh G; Weis N; Hellstrand K; Alaeus A; Lagging M
Scand J Infect Dis; 2010 Dec; 42(11-12):896-901. PubMed ID: 20608766
[TBL] [Abstract][Full Text] [Related]
13. Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients.
Nilsson J; Weiland O
Scand J Infect Dis; 2010 Jul; 42(6-7):533-9. PubMed ID: 20214543
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and virologic parameters in patients co-infected with hepatitis C and HIV versus patients with hepatitis C mono-infection.
Butt AA; Tsevat J; Ahmad J; Shakil AO; Mrus JM
Am J Med Sci; 2007 May; 333(5):271-5. PubMed ID: 17505167
[TBL] [Abstract][Full Text] [Related]
15. Undetectable hepatitis C virus RNA during syphilis infection in two HIV/HCV-co-infected patients.
Salado-Rasmussen K; Knudsen A; Krarup HB; Katzenstein TL; Gerstoft J
Scand J Infect Dis; 2014 Sep; 46(9):617-23. PubMed ID: 24934985
[TBL] [Abstract][Full Text] [Related]
16. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
Zeitoun JD; Mallet V; Chaix ML; Viard JP; Blanche S; Pol S
J Clin Virol; 2007 Sep; 40(1):71-3. PubMed ID: 17658294
[TBL] [Abstract][Full Text] [Related]
17. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
[TBL] [Abstract][Full Text] [Related]
18. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
19. Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy.
Grint D; Peters L; Reekie J; Soriano V; Kirk O; Knysz B; Suetnov O; Lazzarin A; Ledergerber B; Rockstroh JK; Mocroft A;
HIV Med; 2013 Jul; 14(6):370-8. PubMed ID: 23534815
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy.
Barreiro P; Labarga P; Fernández-Montero JV; Poveda E; de Mendoza C; Sánchez C; Vispo E; Soriano V
J Clin Virol; 2013 Oct; 58(2):391-5. PubMed ID: 23910933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
